Ken Fisher’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ken Fisher’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,861	Closed	-$1.22M	–	1224
2023 Q2	$1.22M	Hold	9,861	–	–	﹤0.01%	739
2023 Q1	$1.44M	Sell	9,861 -140	-1%	-$20.7K	﹤0.01%	706
2022 Q4	$1.59M	Buy	+10,001	New	+$1.47M	﹤0.01%	686
2018 Q1	–	Sell	-1,606	Closed	-$216K	–	801
2017 Q4	$216K	Hold	1,606	–	–	﹤0.01%	815
2017 Q3	$235K	Sell	1,606 -290	-15%	-$43.9K	﹤0.01%	726
2017 Q2	$295K	Hold	1,896	–	–	﹤0.01%	654
2017 Q1	$275K	Hold	1,896	–	–	﹤0.01%	637
2016 Q4	$207K	Sell	1,896 -110	-5%	-$12.3K	﹤0.01%	683
2016 Q3	$244K	Buy	2,006 +147	+8%	+$19.8K	﹤0.01%	653
2016 Q2	$261K	Sell	1,859 -90	-5%	-$13.3K	﹤0.01%	622
2016 Q1	$282K	Buy	1,949 +90	+5%	+$11.2K	﹤0.01%	618
2015 Q4	$261K	Buy	1,859 +134	+8%	+$18.6K	﹤0.01%	643
2015 Q3	$229K	Buy	1,725 +425	+33%	+$73.2K	﹤0.01%	618
2015 Q2	$229K	Hold	1,300	–	–	﹤0.01%	541
2015 Q1	$225K	Buy	+1,300	New	+$223K	﹤0.01%	523

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ken Fisher's JAZZ Position: Q3 2023 in Review

Ken Fisher sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 9,861 shares — an estimated $1.22M sold.

Ken Fisher first reported a position in JAZZ in Q1 2015 and held it in 15 quarters. The position peaked at $1.59M in Q4 2022. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

Ken Fisher reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 9,861 Jazz Pharmaceuticals shares in Q3 2023, an estimated $1.22M.
Ken Fisher first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 15 quarters.
Ken Fisher's Jazz Pharmaceuticals position peaked at $1.59M in Q4 2022.
484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.